Tìm kiếm
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Effectiveness Bank Matrix Cell: Can Medications Make It *Too* Easy to Recover?
Drug-based treatments dominate opiate addiction treatment but are far from universally accepted. Referring to chemical ‘solutions’ to addiction, the ‘bite’ commentary on this cell ends with the “curious possibility that precisely because a...
Guía de intervención mhGAP para los trastornos mentales, neurológicos y por consumo de sustancias en el nivel de atención de salud no especializada. Versión 2.0
Los trastornos mentales, neurológicos y por consumo de sustancias (MNS) son muy frecuentes y representan una gran carga de enfermedad y discapacidad a nivel mundial. Subsiste una amplia brecha entre la capacidad de los sistemas de salud y...
mhGAP Intervention Guide - Version 2.0 for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings
Overview
This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings. It is for use by doctors, nurses, other health workers as...
Risk of Violence in Drug Rehabilitation Centers
Abstract
Background
In 2009, Mexico reformed its health law to partially decriminalize drug possession considered for personal use and to increase mandatory referrals to certified drug rehabilitation centers in lieu of incarceration...
Guía de práctica clínica: Tratamiento del síndrome de abstinencia alcohólica, 2ª edición
Este documento responde a la necesidad de tener en la práctica clínica herramientas estandarizadas para el manejo integral del síndrome de abstinencia alcohólica. El grupo de trabajo que desarrolló este documento se basó en la Guía de...
The Health and Social Effects of Nonmedical Cannabis Use
Foreword
Cannabis is globally the most commonly used psychoactive substance under international control. In 2013, an estimated 181.8 million people aged 15-64 years used cannabis for nonmedical purposes globally (UNODC, 2015). There is an...
Reduction of Mortality Following Better Detection of Hypertension and Alcohol Problems in Primary Health Care in Spain
Abstract
Through a simulation study, we estimated the potential effects of better detection of hypertension and improved screening for alcohol problems with subsequent interventions. Results showed that if 50% of Spanish males between 40...
Reducción de la mortalidad mediante una mejor detección de la hipertensión y los problemas con el alcohol en atención primaria de salud en España
Resumen
Se estudian mediante una simulación los potenciales beneficios que puede comportar una mejora en la detección y tratamiento de la hipertensión y de los problemas relacionados con el alcohol. Los resultados muestran que si el 50% de...
Contribution of Alcohol Use Disorders to the Burden of Dementia in France 2008–13
Summary
Background
Dementia is a prevalent condition, affecting 5–7% of people aged 60 years and older, and a leading cause of disability in people aged 60 years and older globally. We aimed to examine the association between alcohol use...
Mujeres y Tratamiento de Drogas
Guía de asesoría clínica para programas de tratamiento y rehabilitación en drogas en población específica de mujeres adultas.
Are you an ISSUP member? If not, you can join ISSUP by registering here: https://www.issup.net/membership/apply
...
Is Smoking a Risk Factor for Tinnitus? A Systematic Review, Meta-Analysis and Estimation of the Population Attributable Risk in Germany
Abstract
Objective: To assess the epidemiological association of smoking status and tinnitus with a systematic review and meta-analysis and to estimate the population attributable risk in Germany.
Data sources: A systematic literature...
Certification of Addiction Professionals in Africa: An Overview of the Process in Kenya
Abstract
This paper focuses on Kenya’s course of action to address the drug problem, specifically, treatment and rehabilitation of persons with Substance Use Disorders (SUDs). Treatment and rehabilitation of persons with SUDs was formally...
Extent and Patterns of Drug Use among Persons with Disabilities in Kenya
Abstract
Background: Although some data existed suggesting that there was high prevalence of drug use among the general population in Kenya with 39-48% of 15-65 year olds having used alcohol and at least one other substance, there was a...
Supervised Dosing with a Long-Acting Opioid Medication in the Management of Opioid Dependence
Trials challenge the need for the widely accepted policy of making opioid-dependent patients take their methadone or other opioid substitutes at the clinic or pharmacy, but ‘no difference’ findings may be due to the limitations of the...
Recommendations for NIDA's Cannabis Policy Research Agenda
The National Institute on Drug Abuse (NIDA) has released a new report Recommendations for NIDA's Cannabis Policy Research Agenda.
The document has been prepared by the National Advisory Council on Drug Abuse Workgroup which was formed in...
The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and their Associated Neural Mechanisms
In drug addiction, cues previously associated with drug use can produce craving and frequently trigger the resumption of drug taking in individuals vulnerable to relapse. Environmental stimuli associated with drugs or natural reinforcers...
Alcohol and Drugs Prevention, Treatment and Recovery: Why Invest?
Estimates show that in the UK the social and economic costs of alcohol related harm amount to £21.5bn, while harm from illicit drug use costs £10.7bn. These include costs associated with deaths, the NHS, crime and, in the case of alcohol...
Una guía de bolsillo: Indagación del abuso del alcohol y una intervención breve
Esta guía de bolsillo fue resumida de la guía de 34 páginas del NIAAA, Ayudando a Pacientes que Beben en Exceso: Una Guía Clínica. Los materiales incluyen:
- Folletos educativos para pacientes
- Notas de progreso ya formateadas
- Diapositiva...
Guía para profesionales de la salud - Ayudando a pacientes que beben en exceso
Guía dirigida a profesionales de la salud para el trabajo con personas de consumo de alcohol en exceso
Esta guía ha sido escrita para profesionales de la salud de atención primaria y salud mental. Ha sido producida por el Instituto...
Dual Disorders in Individuals under Treatment for both Alcohol and Cocaine
Abstract
Introduction: Descriptive data about co-occurrence of alcohol and cocaine consumption is scarce, despite its important prevalence. Dual disorders show high prevalence in clinical samples, and patients report worse evolution and...